United States · FDA National Drug Code directory

OLANZAPINE

A source-listed medicine record.

Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.

Medicine identity

Source reference: 13668-088_1a64829a-2434-4c8d-8e58-9b28758e4b88
Product NDC: 13668-088
Form: TABLET, ORALLY DISINTEGRATING
Composition / generic term: OLANZAPINE
Labeler: Torrent Pharmaceuticals Limited
Marketing category: ANDA
Marketing start / end (source format): 20111025
Source listing expiry: 20271231

Source-listed ingredients

OLANZAPINE — 10 mg/1

These values do not establish equivalence or a dose recommendation.

Packages

500 TABLET, ORALLY DISINTEGRATING in 1 BOTTLE (13668-088-05) · 13668-088-05
30 TABLET, ORALLY DISINTEGRATING in 1 BOTTLE (13668-088-30) · 13668-088-30
90 TABLET, ORALLY DISINTEGRATING in 1 BOTTLE (13668-088-90) · 13668-088-90

Source and coverage

Open FDA National Drug Code directory →

Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.

Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.

Browse United States records →